Enanta Pharmaceuticals
ENTA
#8372
Rank
โ‚น15.85 B
Marketcap
โ‚น743.02
Share price
3.43%
Change (1 day)
-30.02%
Change (1 year)

Revenue for Enanta Pharmaceuticals (ENTA)

Revenue in 2024 (TTM): โ‚น5.59 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น5.76 Billion. a decrease over the revenue in the year 2023 that were of โ‚น6.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enanta Pharmaceuticals from 2012 to 2024

2013201620192022โ‚น5Bโ‚น10Bโ‚น15Bโ‚น20Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 โ‚น5.71 B-6.79%
2023 โ‚น6.12 B-9.78%
2022 โ‚น6.79 B-1.84%
2021 โ‚น6.92 B-6.9%
2020 โ‚น7.43 B-44.52%
2019 โ‚น13.39 B-19.63%
2018 โ‚น16.66 B100.05%
2017 โ‚น8.33 B144.08%
2016 โ‚น3.41 B-61.03%
2015 โ‚น8.76 B11.16%
2014 โ‚น7.88 B2407.61%
2013 โ‚น0.31 B-91.66%
2012 โ‚น3.76 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น4.806 T 83,294.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.687 T 133,282.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น953.77 B 16,448.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.467 T 94,768.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.180 T 72,432.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.476 T 77,571.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland